Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Patent
1995-06-05
1996-02-06
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
514678, 514689, A61K 3112
Patent
active
054896142
ABSTRACT:
Known and new catechol derivates may be used as medicinal antioxidants in the prevention or treatment of tissue damage induced by lipid peroxidation. The conditions and diseases to be treated are for example heart disease, rheumatoid arthritis, cancer, inflammatory disease, a rejection reaction in organ transplants, ischemia, cancer and aging.
REFERENCES:
patent: 3804904 (1974-04-01), Bentley et al.
patent: 3886285 (1975-05-01), Bentley et al.
patent: 4618627 (1986-10-01), Murase et al.
Halliwell, "Oxidants and human disease: some new concepts," FASEB J., vol. 1, 1987, pp. 358-364.
Abstract 62-12757, Patent Abstracts of Japan, vol. 11, No. 192 (C-429)[2639], Jun. 19, 1987.
Abstract 1-213276, Patent Abstracts of Japan, vol. 13, No. 523 (C-657)[3871], Nov. 21, 1989.
Metsa-Ketela et al., "Radical-Trapping Antioxidant Properties of Nitecapone," Digestive Diseases and Sciences, vol. 35, No. 8, Aug. 1990.
Fujimoto et al., "Biological Antioxidant Activities of Bromophenols and Certain Other Antioxidants," Agric. Biol. Chem., vol. 50, No. 1, pp. 101-108, 1986.
Suzuki et al., "Antioxidant Properties of Nitecapone (OR-462)," Free Radical Biology & Medicine, vol. 13, pp. 517-525, 1992.
Hearse & Tosaki, J. Mol. Cell. Cardiol. 20:213-223 (1988).
"Catechol O-methyltransferase. 10. 5-Substituted,3-hydroxy-4-methoxybenzoic acids (isovanillic acids) and 5-substituted, 3-hydroxy-4-methoxybenzaldehydes (isovan=illins) as potential inhibitors," Borchardt, Ronald T., et al., Chemical Abstracts, vol. 96, Mar. 1982, p. 81807a.
"A useful synthesis of ethyl indole-2-carboxylates and 3,4-dihydrocarboxtyrils," Mali, R. S., et al., Chemical Abstracts, vol. 102, Apr. 1985, p. 580 (62028y).
"The effect of ring-fluorination on the rate of O-methylation of dihydroxy-phenylalanine (DOPA) by catecho=1-0-methyltransferase: significance in the development of .sup.18 F-PETT scanning agents," Creveling, Cyrus R., et al., Chemical Abstracts, vol. 104: 207624t. Aug. 1989.
"On the secondary products of the synthesis of vanillin from guaiacol and of ethylvanillin from pyrocatechol monoethyl ether; 4-hydroxy-5-methoxy-and 4-hydroxy-5-ethoxyisophthalaldehydes," Favre, Claude, Chemical Abstracts, vol. 48, Jun. 1954, p. 5831.
"Syntheses of heterocyclic compounds. CDXXXV. Nitrenes. IX. Reaction of .beta.-(2-nitrobenzoyl)-2-nitrostyrene derivatives with triethyl phosphite," Kametani, Tetsuji, et al., Chemical Abstracts, vol. 75, p. 308 (151626h), Sep. 1971.
"Synthesis of 2,3-dimethoxy-5-methyl-p-benzoquinone," Sato, Kikumasa, et al., Chemical Abstracts, vol. 78, p. 471 (29377z), Jun. 1973.
Backstrom Reijo J.
Korkolainen Tapio J.
Nissinen Erkki A. O.
Pippuri Aino K.
Fay Zohreh
MacMillan Keith
Orion-yhtyma Oy
LandOfFree
Catechol derivatives, their physiologically acceptable salts, es does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Catechol derivatives, their physiologically acceptable salts, es, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Catechol derivatives, their physiologically acceptable salts, es will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2175437